Publication List
https://orcid.org/0000-0003-1884-3498

Original Articles in PubMed Listed Journals:
[1] Useini D, Schlömicher M, Haldenwang P, Buchwald D, Strauch J. Transapical-transcatheter aortic valve implantation in patients without transvascular options: Modified transapical approach. J Card Surg.2022; 37(6):1635-1641
DOI: 10.1111/jocs.16408
Impact Factor: 1.778

[2] Czerny M, Gottardi R, Puiu P, Bernecker OY, Citro R, Della Corte A, di Marco L, Fink M, Gosslau Y, Haldenwang PL, Heijmen RH, Hugas-Mallorqui M, Iesu S, Jacobsen O, Jassar AS, Juraszek A, Kolowca M, Lepidi S, Marrocco-Trischitta MM, Matsuda H, Meisenbacher K, Micari A, Minatoya K, Park KH, Peterss S, Petrich M, Piffaretti G, Probst C, Reutersberg B, Rosati F, Schachner B, Schachner T, Sorokin VA, Szeberin Z, Szopinski P, Di Tommaso L, Trimarchi S, Verhoeven ELG, Vogt F, Voetsch A, Walter T, Weiss G, Yuan X, Benedetto F, De Bellis A, D Oria M, Discher P, Zierer A, Rylski B, van den Berg JC, Wyss TR, Bossone E, Schmidli J, Nienaber C; Collaborators:, Accarino G, Baldascino F, Böckler D, Corazzari C, D Alessio I, de Beaufort H, De Troia C, Dumfarth J, Galbiati D, Gorgatti F, Hagl C, Hamiko M, Huber F, Hyhlik-Duerr A, Ianelli G, Iesu I, Jung JC, Kainz FM, Katsargyris A, Koter S, Kusmierczyk M, Kolsut P, Lengyel B, Lomazzi C, Muneretto C, Nava G, Nolte T, Pacini D, Pleban E, Rychla M, Sakamoto K, Shijo T, Yokawa K, Siepe M, Sirch J, Strauch J, Sule JA, Tobler EL, Walter C, Weigang E. Impact of the coronavirus disease 2019 (COVID-19) pandemic on the care of patients with acute and chronic aortic conditions. Eur J Cardiothorac Surg. 2021; 59(5): 1096-1102
DOI: 10.1093/ejcts/ezaa452
Impact Factor: 4.191

[3] Useini D, Beluli B, Christ H, Schlömicher M, Ewais E, Patsalis P, Haldenwang P,
Naraghi H, Moustafine V, Bechtel M, Strauch J. Transapical transcatheter aortic valve implantation in patients with aortic diseases. Eur J Cardiothorac Surg 2021; 59(6): 1174-1181.
DOI: 10.1093/ejcts/ezab050
Impact Factor: 4.191

[4] Useini D, Beluli B, Christ H, Schlömicher M, Ewais E, Haldenwang P, Patsalis P, Moustafine V, Bechtel M, Strauch J. Transcatheter aortic valve replacement using the SAPIEN 3 valve versus surgical aortic valve replacement using the rapid deployment INTUITY valve: Midterm outcomes. J Card Surg 2021; 36(2): 610-617
DOI: 10.1111/jocs.15275
Impact Factor: 1.778

[5] Kara K, Kloppe A, Ewers A, Boesche L, Aweimer A, Erdogan H, Schoene D, Schiedat F, Patsalis N, Haldenwang PL, Strauch J, Muegge A, Patsalis PC. Outcomes after transcatheter aortic valve replacement in older patients. Herz 2021; 46(Suppl 2): 222-227
DOI: 10.1007/s00059-020-04986-0
Impact Factor: 1.353

[6] Schlömicher M, Bechtel M, Useini D, Naraghi H, Haldenwang PL, Moustafine V, Strauch JT. Single-Center Outcomes with Rapid Deployment Aortic Valve Replacement. Thorac Cardiovasc Surg. 2021; 69(5): 405-411
DOI: 10.1055/s-0040-1713660
Impact Factor: 1.756

[7] Patsalis PC, Aweimer A, Scharkowski H, Useini D, Haldenwang PL, Strauch JT, Canbay A, Mügge A, Katsounas A. Incidence and Impact of Routine Inflammatory Parameters on Outcome after Transcatheter Aortic Valve Replacement. J Interv Cardiol. 2021: 6628405.
DOI: 10.1155/2021/6628405
Impact Factor: 1.731

[8] Patsalis PC, Kloppe A, Plicht B, Schoene D, Schiedat F, Aweimer A, Kara K, Haldenwang PL, Strauch JT, Buck T, Muegge A. Undersizing but overfilling eliminates the gray zones of sizing for transcatheter aortic valve replacement with the balloon-expandable bioprosthesis. Int J Cardiol Heart Vasc 2020; 30: 100593
DOI: 10.1016/j.ijcha.2020.100593
Impact Factor: 2.239

[9] Schloemicher M, Bechtel M, Taghiyev Z, Naraghi H, Haldenwang PL, Moustafine, V, Strauch JT. Intermediate Outcomes after Rapid Deployment Aortic Valve Replacement in Multiple Valve Surgery. Thorac Cardiovasc Surg. 2020; 68(07): 595-601
DOI: 10.1055/s-0039-1685178
Impact Factor: 1.827

[10] Elghannam M, Aljabery Y, Naraghi H, Moustafine V, Bechte M, Strauch J, Haldenwang P. Minimally invasive aortic root surgery: Midterm results in a 2‐year follow‐up. J Card Surg. 2020; 35(7): 1481-1491
DOI: 10.1111/jocs.14628
Impact Factor: 1.778

[11] Kolijn D, Kovacs A, Herwig M, Lodi M, Sieme M, Alhaj A, Sandner P, Papp Z, Reusch PH, Haldenwang P, Falcao-Pires I, Linke WA, Jaquet K, Van Linthout S, Mügge A, Tschöpe C, Hamdani N. Enhanced cardiomyocyte function in hypertensive rats with diastolic dysfunction and human heart failure patients after acute treatment with Soluble guanylyl cyclase (sGC) activator. Front. Physiol. 2020; 11: 345
DOI: 10.3389/fphys.2020.00345
Impact Factor: 4.134

[12] Herwig M, Kolijn D, Lódi M, Hölper S, Kovács Á, Papp Z, Jaquet K, Haldenwang P, Dos Remedios C, Reusch PH, Mügge A, Krüger M, Fielitz J, Linke WA, Hamdani N. Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D. Front Physiol. 2020; 11: 240
DOI: 10.3389/fphys.2020.00240
Impact Factor: 4.134

[13] Useini D, Haldenwang P, Schlömicher M, Christ H, Naraghi H, Moustafine V, Strauch JT. Mid-Term Outcomes after Transapical and Transfemoral Transcatheter Aortic Valve Implantation for Aortic Stenosis and Porcelain Aorta with a Systematic Review of Transfemoral versus Transapical Approach. Thorac Cardiovasc Surg. 2020; 68(7): 623-632
DOI: 10.1055/s-0039-1692719
Impact Factor: 1.827

[14] Patsalis PC, Alotaibi S, Wolf A, Scholtz W, Kloppe A, Plicht B, Buck T, Haldenwang PL, Strauch JT, Nicolas V, Rudolph V, Mügge A Naber CK. Feasibility of Transfemoral Aortic Valve Implantation in Patients With Aortic Disease and Simultaneous or Sequential Endovascular Aortic Repair. J Invasive Cardiol 2019; 31(10): 289-295
PMID: 31416046
Impact Factor: 1.47

[15] Haldenwang PL, Baumann A, Elghannam M, Schlömicher M, Buchwald D, Klak K, Strauch JT. Two stage weaning strategy using veno-veno-arterial perfusion mode for patients on extracorporeal membrane oxygenation following cardiogenic shock. Perfusion 2019; 34(8): 689‐695
DOI: 10.1177/0267659119841862
Impact Factor: 1.972

[16] Schlömicher M, Taghiyev Z, AlJabery Y, Haldenwang PL, Zumholz M, Sikole M, Useini D, Naraghi H, Moustafine V, Bechtel M, Strauch JT. Rapid deployment aortic valve replacement in a minimal access setting: intermediate clinical and echocardiographic outcomes. Eur J Cardiothorac Surg 2018; 54(2): 354-360
DOI: 10.1093/ejcts/ezy023
Impact Factor: 2.451

[17] Schlömicher M, Taghiyev Z, Al-Jabery Y, Lukas Haldenwang P, Markthaler L, Moustafine V, Maria Laczkovics A, Thomas Strauch J, Bechtel M. Aortic Valve Replacement with the Labcor TLPB Supra™ Porcine Bioprosthesis: Intermediate Clinical and Echocardiographic Outcomes. J Heart Valve Dis. 2017 Jan;26(1):90-97.
PMID: 28544836
Impact Factor: 0.433

[18] Schlömicher M, Bechtel M, Taghiyev Z, Al-Jabery Y, Haldenwang PL, Moustafine V, Strauch JT. The Use of Rapid Deployment Valves in Combined Aortic and Mitral Valve Surgery: One-Year Clinical and Echocardiographic Outcomes.
Innovations (Phila). 2017; 12(3): 201-206
DOI: 10.1097/imi.0000000000000373
Impact Factor: 0.33

[19] Haldenwang PL, Häuser L, Prochnow N, Ziebura D, Baumann A, Sikole M, Schlömicher M, Schmitz I, Christ H, Strauch JT. Low-Flow Lower Body Perfusion for Spinal Protection in a Frozen Elephant Trunk Simulation Model. Eur J Cardiothorac Surg 2016; 50: 963-970
DOI: 10.1093/ejcts/ezw146
Impact Factor: 3.759

[20] Haldenwang PL, Prochnow N, Baumann A, Buchwald D, Häuser L, Schlömicher M, Ziebura D, Schmitz I, Christ H, Strauch JT. Spinal cord ischemia after selective cerebral perfusion in a porcine ‘frozen elephant trunk’ simulation model. Ann Thorac Surg 2015; 99(5): 1624-31
DOI: 10.1016/j.athoracsur.2014.12.069
Impact Factor: 3.021

[21] Schlömicher M, Haldenwang PL, Moustafine V, Bechtel M, Strauch JT. Minimal access rapid deployment aortic valve replacement: initial single-center experience and 12-month outcomes. J Thorac Cardiovasc Surg. 2015; 149(2): 434-40
DOI: 10.1016/j.jtcvs.2014.09.118
Impact Factor: 3.494

[22] Haldenwang PL, Trampisch M, Schlömicher M, Pillokeit N, Rehman A, Garstka N, Bechtel M, Strauch J. Risk factors for acute kidney injury following TA-TAVI or minimally invasive aortic valve replacement: which procedure is less kidney damaging in elderly patients? Thorac Cardiovasc Surg 2014; 62(6): 482-8
DOI: 10.1055/s-0034-1376201
Impact Factor: 2.756

[23] Strauch JT, Scherner M, Haldenwang PL, Madershahian N, Pfister R, Kuhn EW, Liakopoulos OJ, Wippermann J, Wahlers T. Transapical minimally invasive aortic valve implantation and conventional aortic valve replacement in octogenarians. J Thorac Cardiovasc Surg. 2012 Jul; 60(5): 335-42.
DOI: 10.1055/s-0032-1304538
Impact Factor: 2.535

[24] Haldenwang PL, Wahlers T, Himmels A, Wippermann J, Zeriouh M, Kröner A, Kuhr K, Strauch JT. Evaluation of risk factors for transient neurological dysfunction and adverse outcome after repair of acute type A aortic dissection in 122 consecutive patients. Eur J Cardiothorac Surg 2012; 42(5): e115-120
DOI: 10.1093/ejcts/ezs412
Impact Factor: 2.674

[25] Haldenwang PL, Klein T, Neef K, Riet T, Sterner-Kock A, Christ H, Wahlers T, Strauch JT. Evaluation of the use of lower body perfusion at 28°C in aortic arch surgery. Eur J Cardiothorac Surg 2012; 41(5): e100-108, discussion e108-109
DOI: 10.1093/ejcts/ezs079
Impact Factor: 2.674

[26] Haldenwang PL, Bechtel M, Moustafine V, Wippermann J, Wahlers T, Strauch JT. State of the art in neuroprotection during acute type A aortic dissection repair. Perfusion 2012; 27(2)119-126
DOI: 10.1177/0267659111427617
Impact Factor: 0.94

[27] Haldenwang PL, Strauch JT, Amann I, Klein T, Sterner-Kock A, Christ H, Wahlers T. Impact of pump flow rate during selective cerebral perfusion on cerebral hemodynamics and metabolism. Ann Thorac Surg. 2010; 90(6): 1975-84
DOI: 10.1016/j.athoracsur.2010.06.111
Impact Factor: 2.234

[28] Kuhn EW, Liakopoulos OJ, Borys MJ, Haldenwang PL, Strauch JT, Madershahian N, Choi YH, Wahlers T. Statins improve surgical ablation outcomes for atrial fibrillation in patients undergoing concomitant cardiac surgery. Interact Cardiovasc Thorac Surg. 2010; 11(1): 24-28
DOI: 10.1510/icvts.2009.230060
Impact Factor: 0.891

[29] Strauch JT, Scherner M, Haldenwang PL, Pfister R, Kuhn EW, Madershahian N, Rahmanian P, Wippermann J, Wahlers T. Minimally invasive transapical aortic valve implantation and risk of acute kidney injury. Ann Thorac Surg, 2010; 89(2): 465-470
DOI: 10.1016/j.athoracsur.2009.09.090
Impact Factor: 2.234

[30] Haldenwang PL, Strauch JT, Müllem K, Reiter H, Liakopoulos O, Fischer JH, Christ H, Wahlers T. Effect of pressure management during hypothermic selective cerebral perfusion on cerebral hemodynamics and metabolism in pigs. J Thorac Cardiovasc Surg. 2010; 139(6): 1623-1631
DOI: 10.1016/j.jtcvs.2009.10.021
Impact Factor: 2.443

[31] Strauch JT, Haldenwang PL, Müllem K, Schmalz M, Liakopoulos O, Christ H, Fischer J, Wahlers T. Temperature dependence of cerebral blood flow for isolated regions of the brain during selective cerebral perfusion in pigs. Ann Thorac Surg. 2009; 88(5): 1506-1513
DOI: 10.1016/j.athoracsur.2009.07.013
Impact Factor: 2.262

[32] Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch JT, Wittwer T, Dorge H, Stamm C, Wassmer G, Wahlers T. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30000 patients. Eur Heart J, 2008; 29(12): 1548-1559
DOI: 10.1093/eurheartj/ehn198
Impact Factor: 8.917

[33] Strauch JT, Spielvogel D, Haldenwang PL, Zhang N, Weisz D, Bodian C, Tatton N, Griepp RB. Cooling to 10°C and treatment with Cyclosporine A improve cerebral recovery following prolonged hypothermic circulatory arrest in a chronic porcine model. Eur J Cardiothorac Surg, 2005; 27(1): 74-80
DOI: 10.1016/j.ejcts.2004.10.045
Impact Factor: 1.053

[34] Nguyen K, Strauch JT, Srivastava S, Lauten A, Haldenwang P, Zhang N, Vlahakis S, Adams DH. Orthotopic mitral valve replacement with autologous pulmonary valve in a porcine model. J Thorac Cardiovasc Surg. 2004; 127(5): 1527-1529
DOI: 10.1016/j.jtcvs.2003.11.055
Impact Factor: 3.406

[35] Strauch JT, Spielvogel D, Haldenwang PL, Shiang H, Zhang N, Weisz D, Bodian CA, Griepp RB. Changes in regional cerebral blood flow under hypothermic selective cerebral perfusion. Thorac Cardiovasc Surg. 2004; 52(2): 82-89
DOI: 10.1055/s-2004-817874
Impact Factor: 0.932

[36] Strauch JT, Spielvogel D, Haldenwang PL, Lauten A, Zhang N, Weisz D, Bodian C, Griepp RB. Cerebral physiology and outcome after hypothermic circulatory arrest followed by selective cerebral perfusion. Ann Thoracic Surg. 2003; 76(6): 1972-1981
DOI: 10.1016/j.athoracsur.2003.06.006
Impact Factor: 2

[37] Strauch JT, Spielvogel D, Haldenwang PL, Correa RK, deAsla RA, Seissler PE, Baran DA, Gass AL, Lansman SL. Recent improvements in outcome with the Novacor left ventricular assist device. J Heart Lung Transplant, 2003; 22(6): 674-680
DOI: 10.1016/s1053-2498(02)01182-8
Impact Factor: 2.806

[38] Strauch JT, Spielvogel D, Haldenwang PL, Zhang N, Weisz D, Bodian CA, Griepp RB: Impact of hypothermic selective cerebral perfusion compared with hypothermic cardiopulmonary bypass on cerebral hemodynamics and metabolism. Eur J Cardiothorac Surg, 2003; 24(5): 807-816
DOI: 10.1016/s1010-7940(03)00517-7
Impact Factor: 1.58